J.Jpn. Surg. Soc.. 80(11): 1313-1317, 1979
Report on the annual meeting
MALIGNANT TUMORS IN INFANTS AND CHILDREN
|
The First Department of Surgery Hokkaido University School of Medicine, J. Uchino, et al. |
Fifty nine patients with neuroblastoma were treated. The 2 year survival rate was 30.4%. While 70% of the stage IVS patients are surviving, the survival rate is only 3.6% in the stage IV patients.
High dose cyclophosphamide and/or papaverine treatment were administrated in 14 patients. Maturation of neuroblastoma cells was not obtained, but a marked decrease of the tumor size was observed in almost all patients. The primary tumors were resected completely in 7 of the 10 patients after CPM treatment.
Twent teryhe patients with hepatoma were treated. Two of the he! atoblastoma patients survived over 2 years, but 7 patients with adult type hepatoma all died within one year.
As the prosnostic factors in neuroblastoma and nephroblastoma, the catecholamine granules and sarcomatous patterns were discussed.
To read the PDF file you will need Adobe Reader installed on your computer.